Vital Nutrients Fish Oil 1400 (200ml) (Liquid, Lemon Flavour) (Pharmaceutical Grade)

7e599fcf-9e44-4f43-9eab-0ff7a1a401cd-358-358.png
Vital Nutrients Fish Oil 1400 (200ml)  (Liquid, Lemon Flavour) (Pharmaceutical Grade) - supplement facts.JPG
7e599fcf-9e44-4f43-9eab-0ff7a1a401cd-358-358.png
Vital Nutrients Fish Oil 1400 (200ml)  (Liquid, Lemon Flavour) (Pharmaceutical Grade) - supplement facts.JPG

Vital Nutrients Fish Oil 1400 (200ml) (Liquid, Lemon Flavour) (Pharmaceutical Grade)

0.00

Deep Sea Liquid Fish Oil, Cardiovascular Support

Add To Cart

Ultra Pure Fish Oil 1400 (Pharmaceutical Grade) provides the same quality ultra-pure, non-rancid fish oil in a liquid format suitable for infants and children. It can be added to cereals or drinks. Ultra Pure Fish Oil "RS" has a pleasant natural lemon flavour and is generally well-accepted by children.

 

Adequate DHA levels are critical during the last trimester of pregnancy because this is when DHA accumulates in the brain and retina of the foetus. Insufficient DHA has an adverse effect on visual and neurological development, so the last trimester is when supplements for the mother and foetus give greatest benefit (Uauy et al., 2001).

 

In Norway, children born to mothers who were supplemented with cod liver oil (2 g/day of EPA + DHA) during pregnancy and during the first three months of lactation scored higher on mental processing tests at four years of age when compared to children whose mothers were not supplemented with cod liver oil (Helland et al., 2003).

 

Omega-3 deficiencies correlate with behavioral problems such as hyperactivity, anxiety, and disruptive behaviour; sleep difficulties, and learning difficulties in children (Kidd, 2007).

 

In the Oxford-Durham Study, a double-blind randomized control trial was conducted on 117 children aged 5 to 12, comparing a mixed omega-3/omega-6 supplement against an olive oil placebo. The supplement contained 174 mg DHA, 558 mg EPA, and 60 mg GLA, plus 9.6 mg vitamin E. The children on the supplement showed three times the normal expected gain in reading skills and twice the normal gain in spelling competency, plus marked improvement in behavior (Richardson & Montgomery, 2005).

 

After reviewing all the evidence of such studies, Richardson (2006) states that omega-3 status is very relevant to and therapeutically corrective for ADHD and related behavioral disorders such as aggressiveness, anxiety, and disruptive behaviour.

 

Fish oil taken by the mother during breastfeeding and the first two years of an infant's life was found to be effective in reducing atopic (allergy) conditions in childhood (Francois et al., 2003). Children who had adequate omega-3 during gestation and early childhood were 74% less likely to develop asthma (Hodge et al., 1996).

 

Recommended Dosage:

1 teaspoon daily with food or as directed by the healthcare professional.

REFERENCES:

Astarita, G., et al., 2010. Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease. PloS ONE, 5(9), e12538. PMID: 20838618.

 

Broughton, K.S., et al., 1997. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. The American Journal of Clinical Nutrition, 65(4), 1011-1017. PMID: 9094887

 

Crawford, M., 1995. Nutrition and evolution, New Canaan  Conn.: Keats Pub.

 

Francois, C.A., et al., 2003. Supplementing lactating women with flaxseed oil does not increase docosahexaenoic acid in their milk. The American Journal of Clinical Nutrition, 77(1), 226-233. PMID: 12499346.

 

Gleissman, H. et al., 2011. Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo. International Journal of Cancer,128(7):1703-11. PMID: 20499314.

 

Goldberg, R.J. & Katz, J., 2007. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain, 129(1-2), 210-223. PMID: 17335973.

 

Helland, I.B., et al., 2003. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics, 111(1), e39-44. PMID: 12509593.

 

Hodge, L., et al., 1996. Consumption of oily fish and childhood asthma risk. The Medical Journal of Australia, 164(3), 137-140. PMID: 8628130

 

Kelavkar, U.P., et al., 2006. Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy. Neoplasia, 8(2), 112-124. PMID: 16611404.

 

Kidd, P.M., 2007. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Alternative Medicine Review, 12(3), 207-227. PMID: 18072818

 

Kim, J., et al., 2009. Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study. BMC Cancer, 9, 216. PMID: 19566923.

 

Kris-Etherton, P.M., Harris, W.S. & Appel, L.J., 2003. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology, 23(2), 151-152. PMID: 12588750.

 

Lavie, C.J., et al., 2009. Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases. Journal of the American College of Cardiology, 54(7), 585-594. http://linkinghub.elsevier.com/retrieve/pii/S0735109709017094

 

Manna, S., et al., 2008. Dietary fish oil associated with increased apoptosis and modulated expression of Bax and Bcl-2 during 7,12-dimethylbenz(alpha)anthracene-induced mammary carcinogenesis in rats. Prostaglandins, Leukotrienes and Essential Fatty Acids, 79(1-2), 5-14. PMID: 18614344.

 

Marchioli, R., et al., 2002. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation, 105(16), 1897-1903. PMID: 11997274.

 

Mas, E., et al., 2010. The omega-3 fatty acids EPA and DHA decrease plasma F2-isoprostanes: Results from two placebo-controlled interventions. Free Radical Research, 44(9), 983-990.http://informahealthcare.com/doi/abs/10.3109/10715762.2010.492830

Prescott, S.L. & Calder, P.C., 2004. N-3 polyunsaturated fatty acids and allergic disease. Currrent Opinion in Clinical Nutrition & Metabolic Care, 7(2), 123-129. PMID: 15075701.

 

Ramos, E.J.B., et al., 2004. Effects of omega-3 fatty acid supplementation on tumor-bearing rats. Journal of the American College of Surgeons, 199(5), 716-723. PMID: 15501111.

 

Richardson, A.J., 2006. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders. International Review of Psychiatry, 18(2), 155-172. PMID: 16777670.

 

Richardson, A.J. & Montgomery, P., 2005. The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics, 115(5), 1360-1366. PMID: 15867048.

 

Simopoulos, A.P., 1999. Essential fatty acids in health and chronic disease. The American Journal of Clinical Nutrition, 70(3 Suppl), 560S-569S. PMID: 10479232.

 

Strannegård, O. & Strannegård, I.L., 2001. The causes of the increasing prevalence of allergy: is atopy a microbial deprivation disorder? Allergy, 56(2), 91-102. PMID: 11167368.

 

Toriyama-Baba, H., et al., 2001. Organotropic chemopreventive effects of n-3 unsaturated fatty acids in a rat multi-organ carcinogenesis model. Japanese Journal of Cancer Research, 92(11), 1175-1183. PMID: 11714441.

 

Uauy, R., et al., 2001. Essential fatty acids in visual and brain development. Lipids, 36(9), 885-895. PMID: 11724460